Related Experiment Videos
Pulmonary carcinogenesis in transgenic mice.
R R Maronpot1, R D Palmiter, R L Brinster
1National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina.
Experimental Lung Research
|March 1, 1991
Summary
Genetically engineered mice with a mutated H-ras gene develop lethal lung tumors. These models offer insights into tumor development and potential anticancer drug testing.
Area of Science:
- Oncology
- Genetics
- Animal Models
Background:
- Genetically engineered mice are valuable tools for studying cancer development.
- Understanding factors influencing tumor progression is crucial for developing effective treatments.
Purpose of the Study:
- To characterize lung tumors in three transgenic mouse lines harboring a mutated human H-ras gene.
- To evaluate the utility of these models for cancer research and therapeutic development.
Main Methods:
- Conventional histopathologic and ultrastructural techniques were employed.
- Three lines of transgenic mice with an albumin enhancer/promoter linked to a mutated H-ras gene were analyzed.
Main Results:
- All three mouse lines developed lethal alveolar-bronchiolar (A/B) adenocarcinomas.
- Tumor morphological diversity and growth rates suggest secondary event involvement.
- Two lines showed rapid A/B neoplasm development, suitable for chemotherapeutic agent testing.
- One line exhibited slower tumor development and bronchiogenic tumors, offering a different research model.
Conclusions:
- Transgenic mouse models with mutated H-ras provide valuable platforms for studying lung tumor development.
- These models can be utilized to investigate factors influencing tumor phenotype and biological behavior.
- The characterized transgenic lines are promising for preclinical evaluation of anticancer drugs.